Therapeutics Bridge Labs (TxBL), launched by MSK in 2025 and embedded within OEC, represents a unique strategic asset among New York City academic research institutions.
Subscribe to our email newsletter to get MSK’s latest information on cancer care and research. No one should go through prostate cancer alone. At MSK, our team of prostate cancer experts is here for ...
Some cancer treatments, including chemotherapy and radiation therapy to the head and neck, may affect the cells that are in your mouth and digestive tract. This is known as mucositis (myoo-koh-SY-tis) ...
This information explains how to care for your wound after your skin procedure with sutures (stitches).
If you have questions or concerns, contact your healthcare provider. A member of your care team will answer Monday through Friday from 9 a.m. to 5 p.m. Outside those hours, you can leave a message or ...
This information explains how to shower using 4% chlorhexidine gluconate (CHG) solution. CHG solution is a skin cleanser that keeps working after you use it. CHG is a strong antiseptic (liquid used to ...
Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...
Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...
Getting rid of your home medical sharps If you live in New York City, you can place the sealed container with your regular trash for collection. Do not put it with your recyclable trash. If you live ...
Thoracic oncologist Kathryn Arbour, MD, led the Phase 1/2 clinical trial of daraxonrasib at MSK for metastatic lung cancer. The drug was approved by the FDA for pancreatic cancer in August 2026 and Dr ...
Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...
This information explains what pancreatic enzyme replacement therapy (PERT) is and how it works. Your pancreas makes pancreatic enzymes to help you digest food. Some diseases or treatments may stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results